NL-OMON52711招募中不适用
Target Activated Clotting Time for anticoagulation during cardiopulmonary bypass - TACT study
Perfusie0 个研究点目标入组 1,010 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,010
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass
- •including coronary artery bypass grafting, valve surgery or a combination of
- •Informed consent.
排除标准
- •re-operations
- •aorta surgery
- •emergency operation
- •minimized extracorporeal circuits
- •deep hypothermia (<32 degrees Celsius)
- •patients with congenital or aquired coagulation factor abnormatlities
- •patients with anemia (hemoglobin values < 6.5 mmol/l)
研究者
相似试验
尚未招募
不适用
Target Activated Clotting time for anticoagulation during cardiopulmonary bypassNL-OMON27592niversity Medical Center Utrecht1,536
尚未招募
不适用
Measuring the Activated Clotting Time in patients receiving unfractionated heparin prior to coronary angiography and intervention. A single-centre validation study comparing different blood sampling sitesNL-OMON44549oordwest Ziekenhuisgroep100
撤回
不适用
Measuring the Activated Clotting Time in patients receiving unfractionated heparin prior to coronary angiography and intervention. A single-centre validation study comparing different blood sampling sitesNL-OMON43038Medisch Centrum Alkmaar100
尚未招募
3 期
Deciding the duration of blood thinners following acute venous thromboembolism (VTE) by assessing residual venous thrombosis by ultrasound scaCTRI/2023/06/053767Indian Council of Medical Research
招募中
4 期
Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients with CancerPulmonary embolismJPRN-jRCTs051200135Ono Koh330